文献速递前列腺癌

早期医疗补助扩展州的前列腺癌筛查变化

Prostate Cancer Screening in Early Medicaid Expansion States.
PubMed 文献 · J Urol · 2017-07-29

利用2012和2014年BRFSS调查数据,分析40至64岁男性过去12个月PSA检测情况。全国筛查率在2011至2013年间下降(OR 0.87,95%CI 0.83-0.91),但在早期扩展医疗补助的州,联邦贫困线低于138%的男性筛查率绝对增加3%,且与扩展状态相关(交互作用P=0.04)。结论认为这反映了历史上就医障碍人群预防服务可及性的改善。

要点

  • 全国PSA筛查率在2011至2013年间下降,OR 0.87(95%CI 0.83-0.91)。
  • 早期扩展州联邦贫困线低于138%的男性PSA筛查率绝对增加3%,交互作用P=0.04。
  • 早期扩展州中55至59岁、非西班牙裔非洲裔美国人、西班牙裔、离异、非高中毕业生及当前吸烟者筛查也增加。

核心结论

  • 2011至2013年间全国前列腺癌筛查率下降,但早期扩展医疗补助的州高收入与低收入男性间PSA筛查差距显著缩小,可能反映历史上就医障碍人群预防服务可及性的改善。

研究设计与样本

  • 使用2012年和2014年BRFSS调查数据,纳入40至64岁报告过去12个月接受PSA检测的男性,共158,103名受访者,采用多变量逻辑回归和交互分析。

主要发现

  • 非扩展州受访者的PSA筛查发生率最高。
  • 全国范围内2011至2013年筛查下降(OR 0.87,95%CI 0.83-0.91)。
  • 仅在早期扩展州,联邦贫困线低于138%的男性筛查率绝对增加3%,且与扩展状态相关(交互作用P=0.04)。
  • 早期扩展州中55至59岁、非西班牙裔非洲裔美国人、西班牙裔、离异、非高中毕业生及当前吸烟者的筛查也增加。

关键数值与推荐

  • 收入按与医疗补助资格及联邦贫困线的关系分层:低于138%、138%至400%、高于400%。
  • 全国筛查下降OR 0.87(95%CI 0.83-0.91)。
  • 早期扩展州联邦贫困线低于138%男性筛查绝对增加3%,交互作用P=0.04。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The PPACA (Patient Protection and Affordable Care Act) of 2010 included a provision to expand Medicaid by 2014. Six states and jurisdictions elected to expand Medicaid early before 2012. This provided a natural experiment to test the association between expanded insurance coverage and preventive service utilization, including prostate cancer screening. MATERIALS AND METHODS: Using the 2012 and 2014 BRFSS (Behavioral Risk Factor Surveillance System) surveys we identified men 40 to 64 years old who reported prostate specific antigen testing in the preceding 12 months. Sociodemographic and access to care variables were extracted. Income was stratified by the relationship to Medicaid eligibility and the federal poverty level (less than 138%, 138% to 400% and greater than 400%). The weighted prevalence of prostate specific antigen was estimated. Multivariable logistic regression models were used to evaluate factors associated with prostate specific antigen screening. Interaction analysis for Medicaid expansion was performed. RESULTS: Among 158,103 respondents individuals in nonexpansion states had the highest incidence of prostate specific antigen screening. Nationally screening decreased between 2011 and 2013 (OR 0.87, 95% CI 0.83-0.91). In only early expansion states there was a 3% absolute increase in screening among men in the less than 138% federal poverty level, which was associated with expansion status (pinteraction = 0.04). Increased screening in early expansion states was also seen in men who were 55 to 59 years old, nonHispanic African American, Hispanic, previously married, not high school graduates and current smokers. CONCLUSIONS: Between 2011 and 2013 there were national declines in prostate cancer screening. However, there was significant narrowing of the gap in prostate specific antigen screening between higher and low income men in Medicaid early expansion states. This may reflect improved access to preventive services among populations with historic barriers to care.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Sammon JD, Serrell EC, Karabon P, et al. Prostate Cancer Screening in Early Medicaid Expansion States. J Urol. 2017. PMID: 28765069. doi:10.1016/j.juro.2017.07.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。